Delivery Order SPE2DB25D9312-SPE2DB25FWUUD

Award Date 5/29/25
Potential Completion Date 6/20/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, with a ceiling value of $2,083.12, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract valued at $7,104.00, with a period of performance through May 20, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger...
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,041.56 and an ultimate completion date of March 11, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999...
This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, a ceiling value of $3,124.68, and an ultimate completion date of April 29, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The total ceiling value of the contract is $11,840.00, and it is structured as a firm fixed-price delivery order with no set-aside designation. The contract has an ultimate completion date of August 28, 2024. DMS...
This federal contract award is for the delivery of Mirena 52 mg systems, a contraceptive implant, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,184 and a period of performance through July 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
This federal contract award is for the delivery of Mirena 52 mg Systems, a type of intrauterine device, to the Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order type, with a ceiling value of $4,736.00 and an ultimate completion date of December 26, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $7,104.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $59,200.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with a period of performance through April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB20D9354 with the DLA, which has a ceiling value of up...
  • SPE2DB25D9312
    Indefinite Delivery Contract
  • SPE2DB25D9312-SPE2DB25FWUUD
    Delivery Order

This federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The single-award, firm-fixed-price delivery order contract has a ceiling value of $12,498.48 and is set to expire on June 20, 2025.

DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 8/31/25, 12:51 AM